Pharma Stocks

Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results

Traws Pharma, Inc. Private financing of up to $60M offering of common stock (with $10M upfront) and milestone-based warrants expected…

Read More »

Rajesh Palviya of Axis Sec suggests Ajanta Pharma, Tata Communications, NMDC shares to buy today – 15 May

Stock market today: Benchmark equity indices Sensex and Nifty 50 opened higher on Friday, 15 May, supported by gains in…

Read More »

Vertex Pharmaceuticals (VRTX) Is Up 6.0% After New ESOP Shelf, CASGEVY Deal And Guidance Reaffirmation

In early May 2026, Vertex Pharmaceuticals filed a new US$2.87 billion shelf registration for 6,400,000 common shares tied to its employee…

Read More »

Doximity Flags Pharma Ad Market Weakness – Doximity (NYSE:DOCS)

Doximity, an operator of an online networking service for medical professionals, reported fourth-quarter revenue of $145.4 million, up 5% year…

Read More »

Latest financials and China pharma exposure

Sinopharm Group Co Ltd, China’s leading pharmaceutical distributor, reported trailing twelve-month revenue of CNY 332.22 billion as of recent data,…

Read More »

Why Milestone Pharmaceuticals Stock Wilted on Wednesday

Not many investors were willing to walk a mile with Milestone Pharmaceuticals (MIST 9.47%) on Hump Day. Shares of the…

Read More »

Morgan Stanley Increases Price Goal on Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the 8 Most Promising Biotech Stocks to Buy Now. On May 1, Morgan…

Read More »

Strong Momentum Meets Stretched Valuations as Bliss GVS P…

Price Action and Recent Performance Extending its winning streak to three consecutive sessions, Bliss GVS Pharma Ltd has gained 3.21%…

Read More »

We Think That There Are Some Issues For Ajanta Pharma (NSE:AJANTPHARM) Beyond Its Promising Earnings

The market for Ajanta Pharma Limited’s (NSE:AJANTPHARM) stock was strong after it released a healthy earnings report last week. Despite…

Read More »

Hantavirus Outbreak Sparks Rollercoaster Ride for Biotech Stocks

A localized hantavirus outbreak aboard an Atlantic cruise ship triggered a brief, speculative frenzy in biotechnology stocks this week. Shares…

Read More »